NCT03526471View on ClinicalTrials.gov

Omega™ Left Atrial Appendage (LAA) Occluder in Patients With Non-Valvular Atrial Fibrillation

NACompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

January 30, 2020

Study Completion Date

March 31, 2020

Conditions

Atrial Fibrillation

Interventions

DEVICE

Omega™ Left Atrial Appendage (LAA) Occluder

catheter delivery of Omega device in the left atrial appendage

Trial Locations (2)

2100

Rigshospitalet, Copenhagen

12000

Chulalongkorn University, Pathum Wan

Sponsors

Collaborators (1)

MedPass International

All Listed Sponsors

collaborator

MedPass International

INDUSTRY

lead

Vascular Innovations Co. Ltd.

INDUSTRY